References

1. Ruiz JG, Ruiz-Peláez JG, Charpak N. Epidemia de displasia broncopulmonar: incidencia y factores asociados en una cohorte de niños prematuros en Bogotá, Colombia. Biomédica 2014;34:29–39.
2. Charpak N, Ruiz JG, Motta S. Curso clínico y pronóstico a un año de una cohorte de pre maturos dados de alta con oxígeno domiciliario en Bogotá, Colombia. Rev Salud Publica 2012;14(1):102–115.
3. Montealegre-Pomar A del P, Charpak N. Anemia, nutrition, and ambulatory oxygen weaning in a cohort of oxygen-dependent premature infants. Pediatr Pulmonol 2021;56(6):1601–1608.
4. Collins JJP, Tibboel D, de Kleer IM, Reiss IKM, Rottier RJ. The future of bronchopulmonary dysplasia: Emerging pathophysiological concepts and potential new avenues of treatment. Front Med 2017;4(MAY):1–17.
5. Mandell EW, Kratimenos P, Abman SH, Steinhorn RH. Drugs for the Prevention and Treatment of Bronchopulmonary Dysplasia. Clin Perinatol 2019;46(2):291–310.
6. Jensen EA. What is bronchopulmonary dysplasia and does caffeine prevent it? Semin Fetal Neonatal Med 2020;25(6):101176.
7. Iyengar A, Davis JM. Drug therapy for the prevention and treatment of bronchopulmonary dysplasia. Front Pharmacol 2015;6(FEB):1–7.
8. Armanian AM, Badiee Z, Afghari R, Salehimehr N, Hassanzade A, Sheikhzadeh S, Shariftehrani M, Rezvan G. Reducing the incidence of chronic lung disease in very premature infants with aminophylline. Int J Prev Med 2014;5(5):569–576.
9. Spina D, Page CP. Xanthines and Phosphodiesterase Inhibitors. In: Handbook of experimental pharmacology. Vol. 237. Germany; 2017. p. 63–91.
10. Pacifici GM. Clinical pharmacology of theophylline in preterm infants: effects, metabolism and pharmacokinetics. Curr Pediatr Rev 2014;10(4):297–303.
11. Gitomer JJ, Khan AM, Ferris ME. Treatment of severe theophylline toxicity with hemodialysis in a preterm neonate. Pediatr Nephrol 2001;16(10):784–786.
12. Visitsunthorn N, Udomittipong K, Punnakan L. Theophylline toxicity in Thai children. Asian Pacific J Allergy Immunol 2001;19(3):177–182.
13. Journey J, Bentley T. Theophylline toxicity. StatPearls [Internet] 2022.
14. Ruiz-Peláez JGJ, Charpak N. Evidence-Based Clinical Practice Guidelines for an Optimal Use of the Kangaroo Mother Method in Preterm and/or Low Birth Weight Infants. Fundación Canguro, editor. Colombia; 2007. 1–196 p.
15. Charpak N, Villegas J. Actualización de los lineamientos técnicos para la implementación de Programas Madre Canguro en Colombia, con énfasis en la nutrición del neonato prematuro o de bajo peso al nacer. Minist Heal Soc Prot Colomb 2017:1–191.
16. Montealegre-Pomar A, Charpak N. Individual factors determine how long infants born preterm or with a low birth weight need to be kept in the Kangaroo position. Acta Paediatr Int J Paediatr 2022;111(2):305–306.
17. Fenton TR, Kim JH. A systematic review and meta-analysis to revise the Fenton growth chart for preterm infants. BMC Pediatr 2013;13:59.
18. Isayama T, Lee SK, Yang J, Lee D, Daspal S, Dunn M, Shah PS. Revisiting the definition of bronchopulmonary dysplasia effect of changing panoply of respiratory support for preterm neonates. JAMA Pediatr 2017;171(3):271–279.
19. Northway WH, Rosan RC, Porter DY. Pulmonary disease following respiratory therapy of Hialine-Membrane Disease. N Engl J Med 1967;276(7):357–368.
20. Villamor-Martinez E, Álvarez-Fuente M, Ghazi AMT, Degraeuwe P, Zimmermann LJI, Kramer BW. Association of Chorioamnionitis With Bronchopulmonary Dysplasia Among Preterm Infants: A Systematic Review, Meta-analysis, and Metaregression. JAMA Netw open 2019;2(11):e1914611.
21. Bancalari E, Claure N. Definitions and Diagnostic Criteria for Bronchopulmonary Dysplasia. Semin Perinatol 2006;30(4):164–170.
22. Jain D, Bancalari E. Bronchopulmonary dysplasia: clinical perspective. Birth Defects Res Part A - Clin Mol Teratol 2014;100(3):134–144.
23. Higgins RD, Jobe AH, Koso-Thomas M, Bancalari E, Viscardi RM, Hartert T V., Ryan RM, Kallapur SG, Steinhorn RH, Konduri GG, et al. Bronchopulmonary Dysplasia: Executive Summary of a Workshop. J Pediatr 2018;197:300–308.
24. Thébaud B, Goss KN, Laughon M, Whitsett JA, Abman SH, Steinhorn RH, Aschner JL, Davis PG, McGrath-Morrow SA, Soll RF, et al. Bronchopulmonary dysplasia. Nat Rev Dis Prim 2019;5(1).
25. Matter LM, El-rokh ESM, Alshekhepy HA. Ameliorating effect of amiodarone versus propranolol in chronic theophylline toxicity in rats. 2019;2176(June):2167–2176.
26. Taha D, Kirkby S, Nawab U, Dysart KC, Genen L, Greenspan JS, Aghai ZH. Early caffeine therapy for prevention of bronchopulmonary dysplasia in preterm infants. J Matern Neonatal Med 2014;27(16):1698–1702.
27. Alhersh E, Abushanab D, Al-Shaibi S, Al-Badriyeh D. Caffeine for the Treatment of Apnea in the Neonatal Intensive Care Unit: A Systematic Overview of Meta-Analyses. Pediatr Drugs 2020;22(4):399–408.
28. Park HW, Lim G, Chung SH, Chung S, Kim KS, Kim SN. Early caffeine use in very low birth weight infants and neonatal outcomes: A systematic review and meta-analysis. J Korean Med Sci 2015;30(12):1828–1835.
29. Gianni ML, Roggero P, Colnaghi MR, Piemontese P, Amato O, Orsi A, Morlacchi L, Mosca F, Giannì ML, Roggero P, et al. The role of nutrition in promoting growth in pre-term infants with bronchopulmonary dysplasia: A prospective non-randomised interventional cohort study. BMC Pediatr 2014;14(1):1–6.
30. Rocha G, Guimarães H, Pereira-Da-silva L. The role of nutrition in the prevention and management of bronchopulmonary dysplasia: A literature review and clinical approach. Int J Environ Res Public Health 2021;18(12).
31. Villamor-Martínez E, Pierro M, Cavallaro G, Mosca F, Villamor E. Mother’s own milk and bronchopulmonary dysplasia: A systematic review and meta-analysis. Front Pediatr 2019;7(JUN):1–9.
32. Conde-Agudelo A, Díaz-Rossello J. Kangaroo mother care to reduce morbidity and mortality in low-birth-weight infants. Cochrane Database Syst Rev 2016;(8):1–148.
33. Boundy EO, Dastjerdi R, Spiegelman D, Fawzi WW, Missmer SA, Lieberman E, Kajeepeta S, Wall S, Chan GJ, Wafaie W. Kangaroo Mother Care and Neonatal Outcomes: A Meta-analysis. Rev Artic Pediatr 2016;137(1):1–16.
34. Aranda J V, Chemtob S, Laudignon N, Sasyniuk BI. Pharmacologic effects of theophylline in the newborn. J Allergy Clin Immunol 1986;78(4 Pt 2):773–780.
35. Wemhöner A, Ortner D, Tschirch E, Strasak A, Rüdiger M. Nutrition of preterm infants in relation to bronchopulmonary dysplasia. BMC Pulm Med 2011;11(7):1–6.
36. Poindexter BB, Martin CR. Impact of Nutrition on Bronchopulmonary Dysplasia. Clin Perinatol 2015;42(4):797–806.
37. Ng G, da Silva O, Ohlsson A. Bronchodilators for the prevention and treatment of chronic lung disease in preterm infants. Cochrane Database Syst Rev 2016;2016(12).